MetLife Investment Management, LLC
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,558
+$117,523 QoQ
Shares Held
26,057
+5.9% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 158 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,145,499 across 249 Biotechnology names. FDMT ranks #151 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in FDMT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,558 | 26,057 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $229,035 | 24,601 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $188,190 | 25,092 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $159,904 | 18,401 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $124,106 | 33,452 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $92,846 | 28,745 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $197,150 | 35,395 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $314,387 | 29,083 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $610,452 | 29,083 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $672,246 | 21,100 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $427,486 | 21,100 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $268,603 | 21,100 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $314,038 | 17,379 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $298,745 | 17,379 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $385,987 | 17,379 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $139,727 | 17,379 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $121,305 | 17,379 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $262,770 | 17,379 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $245,333 | 11,182 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $215,193 | 7,979 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $177,120 | 4,083 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||